These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 12203663

  • 1. Is epoetin alfa a treatment option for chemotherapy-related anemia in children?
    Büyükpamukçu M, Varan A, Kutluk T, Akyüz C.
    Med Pediatr Oncol; 2002 Oct; 39(4):455-8. PubMed ID: 12203663
    [Abstract] [Full Text] [Related]

  • 2. Early epoetin alfa treatment in children with solid tumors.
    Zoubek A, Kronberger M.
    Med Pediatr Oncol; 2002 Oct; 39(4):459-62. PubMed ID: 12203664
    [Abstract] [Full Text] [Related]

  • 3. A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.
    Ariganello O, Mancuso A, Di Molfetta M, Diana F, Beccaglia P, Cortesi E, De Marinis F.
    Lung Cancer; 2004 Oct; 46(1):119-24. PubMed ID: 15364140
    [Abstract] [Full Text] [Related]

  • 4. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
    Patton J, Kuzur M, Liggett W, Miranda F, Varsos H, Porter L.
    Oncologist; 2004 Oct; 9(1):90-6. PubMed ID: 14755018
    [Abstract] [Full Text] [Related]

  • 5. Interventions for anemia in pediatric cancer patients.
    Ruggiero A, Riccardi R.
    Med Pediatr Oncol; 2002 Oct; 39(4):451-4. PubMed ID: 12203662
    [Abstract] [Full Text] [Related]

  • 6. Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy.
    Granetto C, Ricci S, Martoni A, Pezzella G, Testore F, Mattioli R, Lampignano M, Tacconi F, Porrozzi S, Gasparini G, Mantovani G, EPO-ITA3 Study Group.
    Oncol Rep; 2003 Oct; 10(5):1289-96. PubMed ID: 12883695
    [Abstract] [Full Text] [Related]

  • 7. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N, Sriuranpong V, Suwanrusme H.
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [Abstract] [Full Text] [Related]

  • 8. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B, van de Werf PR, Melissant CF, Brok RG.
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [Abstract] [Full Text] [Related]

  • 9. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
    Witzig TE, Silberstein PT, Loprinzi CL, Sloan JA, Novotny PJ, Mailliard JA, Rowland KM, Alberts SR, Krook JE, Levitt R, Morton RF.
    J Clin Oncol; 2005 Apr 20; 23(12):2606-17. PubMed ID: 15452187
    [Abstract] [Full Text] [Related]

  • 10. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.
    Chang J, Couture F, Young S, McWatters KL, Lau CY.
    J Clin Oncol; 2005 Apr 20; 23(12):2597-605. PubMed ID: 15452188
    [Abstract] [Full Text] [Related]

  • 11. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N, Sriuranpong V.
    J Med Assoc Thai; 2005 May 20; 88(5):607-12. PubMed ID: 16149676
    [Abstract] [Full Text] [Related]

  • 12. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
    Shasha D, George MJ, Harrison LB.
    Cancer; 2003 Sep 01; 98(5):1072-9. PubMed ID: 12942577
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer.
    Welch RS, James RD, Wilkinson PM, Belli F, Cowan RA.
    Cancer J Sci Am; 1995 Sep 01; 1(4):261-6. PubMed ID: 9166486
    [Abstract] [Full Text] [Related]

  • 14. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
    Savonije JH, van Groeningen CJ, Wormhoudt LW, Giaccone G.
    Oncologist; 2006 Feb 01; 11(2):206-16. PubMed ID: 16476841
    [Abstract] [Full Text] [Related]

  • 15. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
    Littlewood TJ, Nortier J, Rapoport B, Pawlicki M, de Wasch G, Vercammen E, Schuette W, Wils J, Freund M, Epoetin Alfa Study Group.
    Hematol Oncol; 2003 Dec 01; 21(4):169-80. PubMed ID: 14735555
    [Abstract] [Full Text] [Related]

  • 16. Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.
    Quirt I, Kovacs M, Couture F, Turner AR, Noble M, Burkes R, Dolan S, Plante RK, Lau CY, Chang J.
    Oncologist; 2006 Jan 01; 11(1):73-82. PubMed ID: 16401716
    [Abstract] [Full Text] [Related]

  • 17. Initiation of epoetin-alpha therapy at a starting dose of 120,000 units once every 3 weeks in patients with cancer receiving chemotherapy: an open-label, multicenter study with randomized and nonrandomized treatment arms.
    Glaspy JA, Charu V, Luo D, Moyo V, Kamin M, Wilhelm FE.
    Cancer; 2009 Mar 01; 115(5):1121-31. PubMed ID: 19170225
    [Abstract] [Full Text] [Related]

  • 18. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH, van Groeningen CJ, Wormhoudt LW, Giaccone G.
    Oncologist; 2006 Feb 01; 11(2):197-205. PubMed ID: 16476840
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A.
    Pediatr Hematol Oncol; 2008 Sep 01; 25(6):509-21. PubMed ID: 18728970
    [Abstract] [Full Text] [Related]

  • 20. Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.
    Schouwink JH, Codrington H, Sleeboom HP, Kerkhofs LG, Wormhoudt LW.
    Eur J Cancer; 2008 Apr 01; 44(6):819-29. PubMed ID: 18343652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.